All Stories

Madrigal touts biomarker data in key MASH population as it works to grow Rezdiffra's reach

The company reported two-year biomarker results from an open-label trial arm testing Rezdiffra in patients with compensated MASH cirrhosis.

May 12, 2025 - 19:27
 0
Madrigal touts biomarker data in key MASH population as it works to grow Rezdiffra's reach
The company reported two-year biomarker results from an open-label trial arm testing Rezdiffra in patients with compensated MASH cirrhosis.
Read More

Tags:

Previous Article

Piano Italia: Fiat assembles first pre-production units of the new 500 Hybrid at...

Next Article

Tiny But Mighty: The MARBERO 30W Solar Panel Is A Steal At 59% Off

Related Posts

Lilly enlists ‘Modern Family’ star for musical Mounjaro campaign

Lilly enlists ‘Modern Family’ star for musical Mounjaro...

May 5, 2025  0

Takeda looks toward 'inflection point' as it eyes new launches to shake off Vyvanse generic impacts

Takeda looks toward 'inflection point' as it eyes new l...

May 8, 2025  0

FDA misses another approval decision target date, this time for GSK's Nucala in COPD

FDA misses another approval decision target date, this ...

May 8, 2025  0